Pulmonary macrophages: Key players in the innate defence of the airways

Thorax

Volumn 70, Issue 12, 2015, Pages 1189-1196

  Byrne, Adam J ^a   Mathie, Sara A ^a   Gregory, Lisa G ^a   Lloyd, Clare M ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ALLERGIC AIRWAY INFLAMMATION; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; ENVIRONMENT; HOMEOSTASIS; HUMAN; IMMUNOREGULATION; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; REVIEW; ANIMAL; IMMUNOLOGY; LUNG DISEASE; PHYSIOLOGY;

ANIMALS; ASTHMA; CYSTIC FIBROSIS; HUMANS; IMMUNITY, INNATE; LUNG DISEASES; MACROPHAGES, ALVEOLAR; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY FIBROSIS; RESPIRATORY TRACT INFECTIONS;

EID: 84957848452     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2015-207020     Document Type: Review

References (94)

1. Metchnikoff E. Leçons sur la pathologie comparée de l''inflammation faites à l''Institut Pasteur en avril et mai 1891.
2. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011;11:723-37.
3. Hussell T, Bell TJ. Alveolar macrophages: plasticity in a tissue-specific context. Nat Rev Immunol 2014;14:81-93.
4. Bedoret D, Wallemacq H, Marichal T, et al. Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice. J Clin Invest 2009;119:3723-38.
5. Franke-Ullmann G, Pförtner C, Walter P, et al. Characterization of murine lung interstitial macrophages in comparison with alveolar macrophages in vitro. J Immunol 1996;157:3097-104.
6. Mantovani A, Sica A, Sozzani S, et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004;25:677-86.
7. Tugal D, Liao X, Jain MK. Transcriptional control of macrophage polarization. Arterioscler Thromb Vasc Biol 2013;33:1135-44.
8. Krausgruber T, Blazek K, Smallie T, et al. IRF5 promotes inflammatory macrophage polarization and Th1-Th17 responses. Nat Immunol 2011;12:231-8.
9. Murray PJ, Allen JE, Biswas SK, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 2014;41:14-20.
10. Xue J, Schmidt SV, Sander J, et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 2014;40:274-88.
11. van Furth R, Cohn ZA. The origin and kinetics of mononuclear phagocytes. J Exp Med 1968;128:415-35. http://jem.rupress.org/content/128/3/415.abstract http://dx.doi.org/10.1084/jem.128.3.415
12. Yona S, Kim K-W, Wolf Y, et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 2013;38:79-91.
13. Jenkins SJ, Ruckerl D, Cook PC, et al. Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 2011;332:1284-8.
14. Schulz C, Gomez Perdiguero E, Chorro L, et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 2012;336:86-90.
15. Hashimoto D, Chow A, Noizat C, et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 2013;38:792-804.
16. Mortaz E, Adcock IM, Tabarsi P, et al. Interaction of pattern recognition receptors with Mycobacterium tuberculosis. J Clin Immunol 2014;35:1-10.
17. Gordon SB, Irving GR, Lawson RA, et al. Intracellular trafficking and killing of Streptococcus pneumoniae by human alveolar macrophages are influenced by opsonins. Infect Immun 2000;68:2286-93. http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=10722631&retmode=ref&cmd=prlinks http://dx.doi.org/10.1128/IAI.68.4.2286-2293.2000
18. Laza-Stanca V, Stanciu LA, Message SD, et al. Rhinovirus replication in human macrophages induces NF- B-dependent tumor necrosis factor alpha production. J Virol 2006;80:8248-58.
19. Chacon-Salinas R, Serafin-Lopez J, Ramos-Payan R, et al. Differential pattern of cytokine expression by macrophages infected in vitro with different Mycobacterium tuberculosis genotypes. Clin Exp Immunol 2005;140:443-9.
20. Jung JY, Madan-Lala R, Georgieva M, et al. The intracellular environment of human macrophages that produce nitric oxide promotes growth of mycobacteria. Infect Immun 2013;81:3198-209.
21. Das R, Koo M-S, Kim BH, et al. Macrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2013;110:E2997-3006.
22. Goldmann O, Kockritz-Blickwede von M, Holtje C, et al. Transcriptome analysis of murine macrophages in response to infection with Streptococcus pyogenes reveals an unusual activation program. Infect Immun 2007;75:4148-57.
23. Taut K, Winter C, Briles DE, et al. Macrophage turnover kinetics in the lungs of mice infected with Streptococcus pneumoniae. Am J Respir Cell Mol Biol 2008;38:105-13.
24. Medeiros AI, Serezani CH, Lee SP, et al. Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 signaling. J Exp Med 2009;206:61-8.
25. Stolberg VR, McCubbrey AL, Freeman CM, et al. Glucocorticoid-augmented efferocytosis inhibits pulmonary pneumococcal clearance in mice by reducing alveolar macrophage bactericidal function. J Immunol 2015;195:174-84.
26. Oliver BGG, Lim S, Wark P, et al. Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages. Thorax 2008;63:519-25.
27. Szabo SM, Levy AR, Gooch KL, et al. Elevated risk of asthma after hospitalization for respiratory syncytial virus infection in infancy. Paediatr Respir Rev 2013;13(Suppl 2):S9-15.
28. Pribul PK, Harker J, Wang B, et al. Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease development. J Virol 2008;82:4441-8.
29. Goritzka M, Makris S, Kausar F, et al. Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes. J Exp Med 2015;212:699-714.
30. Shirey KA, Pletneva LM, Puche AC, et al. Control of RSV-induced lung injury by alternatively activated macrophages is IL-4Ralpha-, TLR4-, and IFN-beta-dependent. Mucosal Immunol 2010;3:291-300.
31. Didierlaurent A, Goulding J, Patel S, et al. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J Exp Med 2008;205:323-9.
32. Page C, Goicochea L, Matthews K, et al. Induction of alternatively activated macrophages enhances pathogenesis during severe acute respiratory syndrome coronavirus infection. J Virol 2012;86:13334-49.
33. Chiang S-F, Lin T-Y, Chow K-C, et al. SARS spike protein induces phenotypic conversion of human B cells to macrophage-like cells. Mol Immunol 2010;47:2575-86.
34. Dosch SF, Mahajan SD, Collins AR. SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-κB pathway in human monocyte macrophages in vitro. Virus Res 2009;142:19-27.
35. Yip MS, Leung NHL, Cheung CY, et al. Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus. Virol J 2014;11:1-11.
36. Traves SL, Culpitt SV, Russell REK, et al. Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD. Thorax 2002;57:590-5. http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=12096201&retmode=ref&cmd=prlinks http://dx.doi.org/10.1136/thorax.57.7.590
37. Keatings VM, Collins PD, Scott DM, et al. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 2012;153:530-4.
38. Ito K, Ito M, Elliott WM, et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 2005;352:1967-76.
39. Berenson CS, Kruzel RL, Eberhardt E, et al. Impaired innate immune alveolar macrophage response and the predilection for COPD exacerbations. Thorax 2014;69:811-8.
40. Hodge S, Hodge G, Scicchitano R, et al. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol Cell Biol 2003;81:289-96.
41. Eltboli O, Bafadhel M, Hollins F, et al. COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils. BMC Pulm Med 2014;14:112.
42. Taylor AE, Finney-Hayward TK, Quint JK, et al. Defective macrophage phagocytosis of bacteria in COPD. Eur Respir J 2010;35:1039-47.
43. Grumelli S, Corry DB, Song L-Z, et al. An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med 2004;1:e8.
44. Shaykhiev R, Krause A, Salit J, et al. Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease. J Immunol 2009;183:2867-83.
45. Chen H, Cowan MJ, Hasday JD, et al. Tobacco smoking inhibits expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-kappaB in alveolar macrophages stimulated with TLR2 and TLR4 agonists. J Immunol 2007;179:6097-106.
46. Xiong Z, Leme AS, Ray P, et al. CX3CR1+ lung mononuclear phagocytes spatially confined to the interstitium produce TNF-α and IL-6 and promote cigarette smoke-induced emphysema. J Immunol 2011;186:3206-14.
47. Bonfield TL, Panuska JR, Konstan MW, et al. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995;152:2111-18.
48. Kopp BT, Abdulrahman BA, Khweek AA, et al. Exaggerated inflammatory responses mediated by Burkholderia cenocepacia in human macrophages derived from Cystic fibrosis patients. Biochem Biophys Res Commun 2012;424:221-7.
49. Assani K, Tazi MF, Amer AO, et al. IFN-γ stimulates autophagy-mediated clearance of Burkholderia cenocepacia in human cystic fibrosis macrophages. PLoS ONE 2014;9:e96681.
50. Tang A, Sharma A, Jen R, et al. Inflammasome-mediated IL-1β production in humans with cystic fibrosis. PLoS ONE 2012;7:e37689.
51. Kotrange S, Kopp B, Akhter A, et al. Burkholderia cenocepacia O polysaccharide chain contributes to caspase-1-dependent IL-1 production in macrophages. J Leukoc Biol 2011;89:481-8.
52. Zhang Y, Li X, Grassme H, et al. Alterations in ceramide concentration and pH determine the release of reactive oxygen species by Cftr-deficient macrophages on infection. J Immunol 2010;184:5104-11.
53. Porto PD, Cifani N, Guarnieri S, et al. Dysfunctional CFTR alters the bactericidal activity of human macrophages against Pseudomonas aeruginosa. PLoS ONE 2011;6:e19970.
54. Murphy BS, Bush HM, Sundareshan V, et al. Characterization of macrophage activation states in patients with cystic fibrosis. J Cyst Fibros 2010;9:314-22.
55. Hofer TP, Frankenberger M, Heimbeck I, et al. Decreased expression of HLA-DQ and HLA-DR on cells of the monocytic lineage in cystic fibrosis. J Mol Med 2014;92:1293-304.
56. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 2012;18:716-25.
57. Broide DH, Lotz M, Cuomo AJ, et al. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 1992;89:958-67.
58. Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000 Prime Rep 2014;6:13.
59. Medoff BD, Seung E, Hong S, et al. CD11b+ myeloid cells are the key mediators of Th2 cell homing into the airway in allergic inflammation. J Immunol 2009;182:623-35. http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=19109196&retmode=ref&cmd=prlinks http://dx.doi.org/10.4049/jimmunol.182.1.623
60. Careau E, Bissonnette EY. Adoptive transfer of alveolar macrophages abrogates bronchial hyperresponsiveness. Am J Respir Cell Mol Biol 2004;31:22-7.
61. Mathie SA, Dixon KL, Walker SA, et al. Alveolar macrophages are sentinels of murine pulmonary homeostasis following inhaled antigen challenge. Allergy 2014;70:80-9.
62. Bang B-R, Chun E, Shim E-J, et al. Alveolar macrophages modulate allergic inflammation in a murine model of asthma. Exp Mol Med 2011;43:275.
63. Toussaint M, Fievez L, Drion P-V, et al. Myeloid hypoxia-inducible factor 1. Mucosal Immunol 2012;6:485-97.
64. Byrne AJ, Jones CP, Gowers K, et al. Lung macrophages contribute to house dust mite driven airway remodeling via HIF-1α. PLoS ONE 2013;8:e69246.
65. Murthy S, Larson-Casey JL, Ryan AJ, et al. Alternative activation of macrophages and pulmonary fibrosis are modulated by scavenger receptor, macrophage receptor with collagenous structure. FASEB J 2015;29:3527-36.
66. Bhatia S, Fei M, Yarlagadda M, et al. Rapid host defense against Aspergillus fumigatus involves alveolar macrophages with a predominance of alternatively activated phenotype. PLoS ONE 2011;6:e15943.
67. Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature 2013;496:445-55.
68. Wynn T, Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis 2010;30:245-57.
69. Osterholzer JJ, Olszewski MA, Murdock BJ, et al. Implicating exudate macrophages and Ly-6Chigh Monocytes in CCR2-dependent lung fibrosis following gene-targeted alveolar Injury. J Immunol 2013;190:3447-57.
70. Schulz C, Perdiguero EG, Chorro L, et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 2012;336:86-90.
71. Stahl M, Schupp J, Jäger B, et al. Lung collagens perpetuate pulmonary fibrosis via CD204 and M2 macrophage activation. PLoS ONE 2013;8:e81382.
72. Piguet PF, Ribaux C, Karpuz V, et al. Expression and localization of tumor necrosis factor-alpha and its mRNA in idiopathic pulmonary fibrosis. Am J Pathol 1993;143:651. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1887194/
73. Raghu G, Brown KK, Costabel U, et al. Treatment of idiopathic pulmonary fibrosis with Etanercept. Am J Respir Crit Care Med 2008;178:948-55.
74. Thavarajah K, Wu P, Rhew EJ, et al. Pulmonary complications of tumor necrosis factor-targeted therapy. Respir Med 2009;103:661-9.
75. Kolb M, Margetts PJ, Anthony DC, et al. Transient expression of IL-1β induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest 2001;107:1529-36.http://www.jci.org/content/vol107/page1529 http://dx.doi.org/10.1172/JCI12568
76. Lappalainen U, Whitsett JA, Wert SE, et al. Interleukin-1β causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am J Respir Cell Mol Biol 2005;32:311-18.
77. Gasse P, Mary C, Guenon I, et al. IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. J Clin Invest 2007;117:3786-99.
78. Li D, Guabiraba R, Besnard A-G, et al. IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice. J Allergy Clin Immunol 2014;134:1422-32.e11.
79. Dostert C, Petrilli V, Van Bruggen R, et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008;320:674-7.
80. Siwik DA, Chang DLF, Colucci WS. Interleukin-1 and Tumor Necrosis Factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res 2000;86:1259-65.
81. Jiang D, Liang J, Fan J, et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 2005;11:1173-9.
82. Pechkovsky DV, Prasse A, Kollert F, et al. Alternatively activated alveolar macrophages in pulmonary fibrosis - mediator productionand intracellular signal transduction. Clin Immunol 2010;137:89-101.
83. Selman M, Ruiz V, Cabrera S, et al. TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? Am J Physiol Lung Cell Mol Physiol 2000;279:L562-74.
84. Gratchev A, Guillot P, Hakiy N, et al. Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3. Scand J Immunol 2001;53:386-92.
85. Parod RJ, Brain JD. Immune opsonin-independent phagocytosis by pulmonary macrophages. J Immunol 1986;136:2041-7.
86. Soukup J. Human alveolar macrophage responses to air pollution particulates are associated with insoluble components of coarse material, including particulate endotoxin. Toxicol Appl Pharmacol 2001;171:20-6.
87. Becker S, Fenton MJ, Soukup JM. Involvement of Microbial Components and Toll-like Receptors 2 And 4 in Cytokine Responses to Air Pollution Particles. Am J Respir Cell Mol Biol 2002;27:611-18.
88. Bauer RN, Müller L, Brighton LE, et al. Interaction with epithelial cells modifies airway macrophage response to ozone. Am J Respir Cell Mol Biol 2015;52:285-94.
89. Goto Y, Ishii H, Hogg JC, et al. Particulate matter air pollution stimulates monocyte release from the bone marrow. Am J Respir Crit Care Med 2004;170:891-7.
90. Shaw CA, Robertson S, Miller MR, et al. Diesel exhaust particulate-exposed macrophages cause marked endothelial cell activation. Am J Respir Cell Mol Biol 2011;44:840-51.
91. Jaguin M, Fardel O, Lecureur V. Exposure to diesel exhaust particle extracts (DEPe) impairs some polarization markers and functions of human macrophages through activation of AhR and Nrf2. PLoS ONE 2015;10:e0116560. doi:10.1371/journal.pone.0116560
92. Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 2000;51:245-70.
93. Stranks AJ, Hansen AL, Panse I, et al. Autophagy controls acquisition of aging features in macrophages. J Innate Immun 2015;7:1-17.
94. Suzuki T, Arumugam P, Sakagami T, et al. Pulmonary macrophage transplantation therapy. Nature 2014;514:450-4.